Combined prediction value of coronary plaque burden, serum creatinine, MLR and NLR in reinfarction risk after PCI in middle-aged and elderly patients with myocardial infarction

冠状动脉斑块负荷、血清肌酐、MLR 和 NLR 联合预测中老年心肌梗死患者经皮冠状动脉介入治疗后再梗死风险的价值

阅读:1

Abstract

OBJECTIVE: To analyze the predictive value of coronary plaque burden combined with serum creatinine (Scr), monocyte/lymphocyte ratio (MLR), and neutrophil/lymphocyte ratio (NLR) in the risk of reinfarction after percutaneous coronary intervention (PCI) in middle-aged and elderly patients with acute myocardial infarction (AMI). METHODS: A retrospective analysis was conducted on the clinical data of 1,582 patients with AMI who underwent PCI in our hospital from January 2021 to January 2024. Based on the occurrence of reinfarction within 6 months post-PCI, patients were divided into a reinfarction group (216 cases) and a non-reinfarction group (1,366 cases). To analyze the risk factors and related predictive values of reinfarction in middle-aged and elderly AMI patients after PCI. RESULTS: Multivariate Logistic regression analysis showed that age, Killip grade, LVEF, cTnI, non-calcified plaque burden, calcified plaque burden, total calcified plaque burden, Scr, MLR, and NLR were all risk factors for reinfarction in middle-aged and elderly AMI patients after PCI (P < 0.05). ROC analysis showed that the combined detection of coronary plaque burden, Scr, MLR and NLR predicted the risk of reinfarction in middle-aged and elderly AMI patients after PCI, and the AUC was 0.998, 95%CI was 0.997 ~ 1.000, the sensitivity was 99.10%, and the specificity was 97.20%, all of them were significantly higher than the individual detection of each index (P < 0.05). CONCLUSION: The combined detection of coronary plaque burden, Scr, MLR and NLR has a high predictive value for reinfarction after PCI in middle-aged and elderly AMI patients, and should be paid close attention to clinically.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。